Goserelin is a synthetic analogue of gonadotropin-releasing hormone (GnRH) used to suppress the production of sex hormones, primarily in the treatment of prostate and breast cancer. Pharmaceutical laboratories… Read more















Goserelin is a synthetic analogue of gonadotropin-releasing hormone (GnRH) used to suppress the production of sex hormones, primarily in the treatment of prostate and breast cancer. Pharmaceutical laboratories rely on this collection of Goserelin reference standards, impurities, and stable isotope labelled compounds to maintain rigorous standards in quality control and analytical testing. The product range includes pharmacopeial and non-pharmacopeial impurities, such as related compounds and specific degradation products, which are essential for precise impurity profiling and the development of robust chromatographic methods. Furthermore, the inclusion of stable isotope labelled versions—such as deuterium-labelled variants—provides the necessary internal standards for accurate mass spectrometry and bioanalytical method validation. Laboratories also utilize these materials, along with specialized system suitability mixtures, to ensure regulatory compliance and the integrity of pharmaceutical testing protocols throughout the drug development lifecycle.